B

Brainsway Ltd
TASE:BWAY

Watchlist Manager
Brainsway Ltd
TASE:BWAY
Watchlist
Price: 1 808 ILS -2.53% Market Closed
Market Cap: 594m ILS
Have any thoughts about
Brainsway Ltd?
Write Note

Brainsway Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Brainsway Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
Brainsway Ltd
TASE:BWAY
Revenue
$31.8m
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
39%
Nano-X Imaging Ltd
NASDAQ:NNOX
Revenue
$9.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inmode Ltd
NASDAQ:INMD
Revenue
$423.7m
CAGR 3-Years
10%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Revenue
$356.4m
CAGR 3-Years
18%
CAGR 5-Years
17%
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Revenue
$50.3m
CAGR 3-Years
127%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Epitomee Medical Ltd
TASE:EPIT
Revenue
$10m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Brainsway Ltd
Revenue Breakdown

Breakdown by Geography
Brainsway Ltd

Total Revenue: 31.8m USD
100%
Country Of U S A: 24m USD
75.4%
Other: 7.8m USD
24.6%

Breakdown by Segments
Brainsway Ltd

Not Available

Brainsway Ltd
Glance View

Market Cap
594m ILS
Industry
Health Care

Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

BWAY Intrinsic Value
2 162.45 ILS
Undervaluation 16%
Intrinsic Value
Price
B

See Also

What is Brainsway Ltd's Revenue?
Revenue
31.8m USD

Based on the financial report for Dec 31, 2023, Brainsway Ltd's Revenue amounts to 31.8m USD.

What is Brainsway Ltd's Revenue growth rate?
Revenue CAGR 10Y
39%

Over the last year, the Revenue growth was 17%. The average annual Revenue growth rates for Brainsway Ltd have been 13% over the past three years , 14% over the past five years , and 39% over the past ten years .

Back to Top